Biogen: Prelude to a Sale?
July 22, 2016 at 11:40 AM EDT
Shares of Biogen ( BIIB ) soared yesterday after the biotech giant announced the departure of its CEO , as well as better-than-expected earnings . Leerink's Geoffrey Porges and Bradley Canino wonder if the turnover in the c-suite is by accident or design:
